Loading clinical trials...
Loading clinical trials...
The Effects of Dutasteride on Mood, HPA Axis, and Serum Allopregnanolone Levels in Women With Menstrual-Related Mood Disorders and Controls
Conditions
Interventions
Dutasteride
Placebo oral capsule
Locations
1
United States
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
Start Date
March 31, 2004
Primary Completion Date
March 6, 2014
Completion Date
March 6, 2014
Last Updated
December 17, 2019
NCT06290258
NCT07310264
NCT00090662
NCT06716502
NCT07225504
NCT07483606
Lead Sponsor
National Institute of Mental Health (NIMH)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions